This content is only available within our institutional offering.

06 Aug 2021
Hikma Pharmaceuticals (Hold) - 1H21 beat, new guidance implies c.2% profit upgrades

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals (Hold) - 1H21 beat, new guidance implies c.2% profit upgrades
Hikma Pharmaceuticals Plc (HIK:LON) | 1,836 275.4 0.8% | Mkt Cap: 4,074m
- Published:
06 Aug 2021 -
Author:
Miles Dixon | Amy Walker | Anchal Verma -
Pages:
6 -